Interim Report for the Period 1. January 2022 – 30. June 2022
Company Announcement
Thursday, September 29, 2022, 10:00 CET
Brain+ A/S (“Brain+”) [BRAINP], today publishes the Interim Report for the Period 1. January 2022 – 30. June 2022
The interim report for the period 1. January 2022 – 30. June 2022 is available as an attached file and can also be read on the Company’s website at https://www.brain-plus.com/investor/announcements_and_financial_documents/
Contact Information
CEO, Kim Baden-Kristensen + 45 31393317, E-mail: kim@brain-plus.com, Brain+ A/S, Købmagergade 53, 3.
Certified Advisor: Keswick Global AG, + 43 1 740 408045 , E-mail: info@keswickglobal.com
About BRAIN+ [BRAINP]
The mission of Brain+ is to restore patients’ independence and quality of life by treating and detecting cognitive decline in Alzheimer’s disease and dementia through software-as-medicine applications. Brain+ has developed a set of software-as-medicine technologies, which enable the Company to create a unique and differentiated product offering. These technologies, combined with a strong clinical pipeline, puts Brain+ in a strong position to grow towards a market leader position in the Digital Therapeutics (DTx) space.
